. Author manuscript; available in PMC: 2018 Mar 1.

Published in final edited form as: Ann Biomed Eng. 2016 Aug 24;45(3):632–643. doi: 10.1007/s10439-016-1716-1

Table 2.

Morphologic parameters in control and PAH groups with/without estrogen treatment

Parameters	CTL_P (n = 10)	CTL_E (n = 10)	SuHx_P (n = 8)	SuHx_E (n = 9)
BW (g)	22.5±0.3	22.1±0.5	20.7±0.3^*	22.0±0.4^#
RV/BW (mg g⁻¹)	0.88±0.03	0.85±0.03	1.59±0.10^*	1.51±0.03^*
RV/Tibia (mg mm⁻¹)	1.08±0.05	1.08±0.06	1.84±0.13^*	1.84±0.05^*
RV/LVS (mg mg⁻¹)	0.28±0.01	0.29±0.01	0.42±0.02^*	0.35±0.01^*^#
RV wall thickness (mm)	0.27±0.02	0.28±0.02	0.36±0.02^*	0.40±0.03^*
RV ID (mm)	1.45±0.03	1.38±0.03	1.31±0.07	1.38±0.09
Main PA ID (mm)	1.34±0.02	1.31±0.03	1.36±0.02	1.40±0.02^*

BW, body weight; RV, RV weight; LVS, left ventricle and septum weight; PA, pulmonary artery; ID, inner diameter.

P<0.05 vs. Control,

P<0.05 vs. Placebo.